|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:668-674
© 2002 The American Association for Thoracic Surgery
General Thoracic Surgery (GTS) |
From the Departments of Thoracic Surgerya and Respiratory Medicine,b Kanazawa Medical University, Uchinada, Ishikawa, Japan, and the Cardiovascular Research Institute, University of California, San Francisco,c San Francisco, Calif.
This study was supported by a Grant for Collaborative Research from Kanazawa Medical University (S00-13, S01-11) and a Grant-In-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (No. 11670600) and National Institutes of Health grant HL51854.
Received for publication July 27, 2001. Revisions requested Nov 19, 2001; revisions received Dec 12, 2001. Accepted for publication Dec 14, 2001. Address for reprints: Tsutomu Sakuma, MD, Thoracic Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan (E-mail: sakumat-t{at}kanazawa-med.ac.jp).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The initial step in alveolar fluid clearance is an uptake of sodium through apical sodium channels on type II alveolar epithelial cells, coupling with subsequent extrusion through basolateral Na+-K+ adenosine triphosphatase.
4,6 The alveolar water volume follows the osmotic gradient created by transported ions from the alveolar spaces into pulmonary interstitium.
4 Amiloride inhibits some apical sodium channels,
6 especially the epithelial sodium channel (ENaC). ß-Adrenergic agonists accelerate sodium and fluid transport in in vivo and ex vivo models.
4,7,8 An important contribution of endogenous catecholamines to alveolar fluid clearance has been reported in rats in septic shock
9 or in hypovolemic shock
10 and in dogs with neurogenic pulmonary edema.
11 In a variety of species, pneumonectomy initiates compensatory growth of the remaining lung in association with the proliferation of type II alveolar epithelial cells.
12-18 However, it is uncertain whether pneumonectomy affects the function of sodium channels and ß2-adrenoceptors in the remaining lung.
Therefore the first objective in this study was to determine the time course of alveolar fluid clearance in pneumonectomized rats. Because alveolar fluid clearance increased 14 and 28 days after pneumonectomy, the second objective was to determine the mechanisms responsible for the increase in alveolar epithelial fluid transport. To answer this question, we determined whether the increase in alveolar fluid clearance depended on amiloride-sensitive transport and whether there was an increase in the expression of
-ENaC mRNA. Also, proliferation of type II alveolar epithelial cells was examined by counting the number of isolated type II cells from the remaining lungs in pneumonectomized rats. Because ß-adrenergic agonists have been shown to increase the resolution of alveolar edema in other models,
7,19,20 as well as perhaps in patients with cardiogenic pulmonary edema,
21 the third objective was to test the efficacy of ß-adrenergic agonists on stimulating alveolar fluid clearance after a pneumonectomy.
| Methods |
|---|
|
|
|---|
We isolated the right lungs from rats that had undergone left pneumonectomy and measured alveolar fluid clearance in the absence of either pulmonary perfusion or ventilation, as previously reported.
22-24 Briefly, rats were anesthetized by means of intraperitoneal administration of pentobarbital sodium (50 mg/kg). An endotracheal tube was inserted through a tracheostomy. Blood samples were obtained from the abdominal aorta for the measurement of plasma catecholamine levels, and then rats were exsanguinated. Through a median sternotomy, the trachea, the right lung, and the heart were excised en bloc. The lungs were wrapped in Saran Wrap to prevent dehydration and were placed in a humidified incubator at 37°C. A warmed physiologic saline solution (0.7 mL/kg) containing 5% bovine albumin and Evans blue dye (0.1 mg/mL) was instilled into the isolated lungs followed by 2 mL of oxygen to deliver all of the instilled fluid into the distal airspaces. The lungs were inflated with 100% oxygen at an airway pressure of 7 cm H2O. Alveolar fluid was aspirated 1 hour after instillation. The concentrations of Evans blue-labeled albumin in the instilled and aspirated solutions were measured with a spectrophotometer at a wavelength of 621 nm (BioSpec-1600; Shimadzu, Kyoto, Japan).
Alveolar fluid clearance
Alveolar fluid clearance was estimated by measuring the increase in the concentrations of alveolar Evans blue-labeled albumin.
22-24 Alveolar fluid clearance (AFC) was calculated as follows:
AFC = [(Vi - Vf)/Vi] x 100,
where V is the volume of the instilled albumin solution (i) and the final alveolar fluid (f). Final alveolar fluid volume (Vf) was calculated as follows:
Vf = (Vi x EBi)/EBf,
where EB is the concentration of Evans blue-labeled albumin in the instilled albumin solution (i) and the final alveolar fluid (f).
By using trichloroacetic acid, greater than 99.5% of Evans blue dye was bound to albumin in the instilled and aspirated solutions.
23
Plasma catecholamine levels
Blood samples were obtained from the abdominal aorta and transferred immediately to chilled tubes containing 0.02 mL of heparin sodium. The blood samples were then centrifuged (1200g for 10 minutes at 4°C), and the plasma samples were stored at -80°C. Plasma catecholamine levels (epinephrine, norepinephrine, and dopamine) were measured by means of high-performance liquid chromatography with a trihydroxyindole reaction.
24
RNA isolation
Total RNA was extracted from perfused rat whole lungs and isolated in type II alveolar epithelial cells by using an RNA isolation kit (Trizol; Gibco BRL, Life Technologies, Rockville, Md). Type II alveolar epithelial cells were isolated from rats 28 days after pneumonectomy. The rat lungs were digested with pancreatic elastase, followed by centrifugation over a discontinuous metrizamide density gradient.
23 The purity of freshly isolated type II cell preparations was 72.4%. When the type II cells were plated for 24 hours, the purity was greater than 95%. The amount of tritiated thymidine uptake was maintained when the cells were plated for 72 hours.
23
Semiquantitative reverse transcription-polymerase chain reaction
DNase I (a RQ1 RNase-free Dnase; Promega, Madison, Wis) was added to the total RNA sample and incubated at 37°C for 15 minutes. The reaction mixture was extracted with phenol/chloroform, and RNA was precipitated with methanol. First-strand DNA was synthesized with random hexamer primers by using a reverse transcriptase (Superscript RT, Gibco BRL). RNase H (Gibco BRL) was added. Designated primers, Taq DNA polymerase (Takara Ex Taq; Takara, Shiga, Japan), and other reaction mixtures were added. The polymerase chain reaction (PCR) was started for 22 cycles at 94°C for 30 seconds, 55°C for 30 seconds, and 72°C for 90 seconds by using a thermal cycler (Gene Amp PCR system 2400; Perkin Elmer, Norwalk, Conn). Aliquots of the PCR product were electrophoresed with 2% agarose gel and stained with ethidium bromide. Primers were 5'-ACGCCTCCAACTCGCCTAAG-3' and 5'-GCCACAGCACCGCCCAGAAG-3' for
-rENaC. Primers for glyceraldehide-3-phosphate dehydrogenase, used as controls, were 5'-ACCCAGAAGACTGTGGATGG-3' and 5'-TGCTGTAGCCGAATTCATTG-3', and PCR was started from 94°C for 16 cycles. The band of
-ENaC mRNA was normalized to the density of the glyceraldehide-3-phosphate dehydrogenase band.
Dry lung weight and protein content
For the measurement of dry lung weight and protein content, the pulmonary artery was flushed with a warmed phosphate buffer solution to remove blood in the pulmonary vessels. The dry lung weight of the right lung was measured by drying the lungs to a constant weight at 70°C for 48 hours. The protein concentrations in the supernatant of the homogenized right lungs were measured with a spectrophotometer at a wavelength of 281 nm (BioSpec-1600; Shimadzu, Kyoto, Japan). Total content of protein was calculated by multiplying the total volume of homogenized lungs.
Specific protocol
Group 1: Time course of alveolar fluid clearance (n = 43)
We measured alveolar fluid clearance and plasma catecholamine levels in rats 3 hours (n = 4), 2 days (n = 4), 7 days (n = 4), 14 days (n = 6), and 28 days (n = 6) after pneumonectomy. As a control, the measurement was carried out on 7 rats immediately after left pneumonectomy. Sham thoracotomy in the absence of the lung resection was performed to determine the effect of thoracotomy, and alveolar fluid clearance was measured 28 days after thoracotomy (n = 8). In addition, Alveolar fluid clearance was measured 28 days after anesthesia in the absence of thoracotomy to determine the effect of anesthesia and ventilation (n = 4).
Group 2: Effect of amiloride on alveolar fluid clearance after pneumonectomy (n = 8)
To determine the mechanisms responsible for the increase in alveolar fluid clearance 28 days after pneumonectomy, we tested the hypothesis that the fraction of amiloride-sensitive alveolar fluid clearance increased in pneumonectomized rats. An albumin solution in the presence of 5 x 10-4 mol/L amiloride, a sodium channel inhibitor, was instilled into the right lungs isolated from control rats (n = 4) and from rats 28 days after pneumonectomy (n = 4).
Group 3: Expression of
-ENaC in the lung and type II alveolar epithelial cells
Because the amiloride-sensitive fraction increased in pneumonectomized rats, the expression of
-ENaC mRNA was measured in the right lung tissue from 4 rats and in the isolated type II alveolar epithelial cells from 4 rats 28 days after pneumonectomy. As controls, the expression of
-ENaC mRNA was measured in the right lung tissue from 4 rats and in the isolated type II alveolar epithelial cells from rats in the absence of pneumonectomy.
Group 4: Proliferation of type II alveolar epithelial cells (n = 16)
To determine whether the proliferation of type II cells increased alveolar fluid clearance in pneumonectomized rats, the proliferation was morphologically examined in the right lungs excised from rats 28 days after pneumonectomy (n = 4) and from normal rats without treatment of left pneumonectomy (n = 4). The excised lungs were instilled with 10% buffered formalin solution gently through a tracheal tube. The trachea was ligated with a silk suture, and then the lungs were placed in 10% buffered formalin solution until the slices of the lungs were paraffin embedded, thin sectioned, and stained with hematoxylin and eosin. The proliferation of the type II cells was examined in the stained specimens by light microscopy. In addition, total numbers of type II alveolar epithelial cells isolated from the right lungs were counted in rats 28 days after pneumonectomy (n = 4) and in age-matched normal rats (n = 4).
Group 5: Effect of terbutaline on alveolar fluid clearance after pneumonectomy (n = 8)
Although alveolar fluid clearance did not increase 3 hours after pneumonectomy, plasma epinephrine levels increased at that time. Therefore we determined whether the remaining lungs were responsive to a ß2-adrenergic agonist. An albumin solution in the presence of 10-5 mol/L terbutaline was instilled into the right lungs in rats 3 hours (n = 4) and 28 days (n = 4) after pneumonectomy.
Statistics
Data are summarized as means and SD. The data were analyzed by means of 1-way analysis of variance with a Student-Newman-Keuls post hoc test when multiple comparisons were needed. When comparisons were made between 2 experimental groups, an unpaired Student t test was used.
| Results |
|---|
|
|
|---|
Time course of alveolar fluid clearance in rats after left pneumonectomy
Alveolar fluid clearance capacity was maintained for 7 days after pneumonectomy and then improved 14 and 28 days after pneumonectomy. Alveolar fluid clearance in the remaining right lungs was 21% ± 2% immediately after left pneumonectomy and did not significantly change over the first 7 days after left pneumonectomy (Figure 1). However, alveolar fluid clearance increased by 47% and 43% at 14 and 28 days after pneumonectomy, respectively (Figure 1
). Anesthesia or thoracotomy in the absence of pneumonectomy had no effect on alveolar fluid clearance 28 days after pneumonectomy (Figure 2). Although plasma epinephrine levels increased minimally but significantly 3 hours after left pneumonectomy, the levels returned to control levels from 2 to 28 days after pneumonectomy (Table 1). Plasma norepinephrine and dopamine levels did not significantly change in pneumonectomized rats.
|
|
|
|
-ENaC in the lung tissue and type II alveolar epithelial cells
-ENaC mRNA and lung growth in the remaining lungs. Dry lung weight and protein content increased in the right lungs in rats 28 days after pneumonectomy (Figure 4). The semiquantitative ratios of
-ENaC mRNA to G3PDH mRNA increased both in whole lung tissue and in isolated type II cells (Figure 4
|
Effect of terbutaline on alveolar fluid clearance after pneumonectomy
The remaining lungs after pneumonectomy were responsive to terbutaline, a ß2-adrenergic agonist. Terbutaline significantly increased alveolar fluid clearance by 38% in control rats (Figure 5). Similarly, terbutaline increased alveolar fluid clearance by 38% in rats 28 days after pneumonectomy (Figure 5
).
|
| Discussion |
|---|
|
|
|---|
We tested 4 hypotheses to account for the increase in alveolar fluid clearance in pneumonectomized rats. Because elevation of endogenous plasma catecholamine levels can increase alveolar fluid clearance,
9-11 the first hypothesis was that endogenous catecholamines would increase alveolar fluid clearance in the remaining lungs in pneumonectomized rats. We sequentially measured plasma catecholamine levels for up to 28 days after left pneumonectomy. Epinephrine levels significantly increased 3 days after pneumonectomy, but the elevation was minimal and inconsistent with the increase in alveolar fluid clearance. In addition, alveolar fluid clearance increased 14 and 28 days after pneumonectomy when plasma epinephrine levels were normal. Therefore it is unlikely that plasma catecholamines played a primary role in the increase in alveolar fluid clearance in pneumonectomized rats.
The second hypothesis was that proliferation of type II alveolar epithelial cells after pneumonectomy played a role in the increase in alveolar fluid clearance in pneumonectomized rats. Some prior reports have indicated that there was an increase in the number of alveolar type II cells after pneumonectomy in rats.
12 We previously reported that the proliferation of type II cells increased alveolar fluid clearance in the remaining human lungs after lobectomy for bronchogenic carcinoma.
13 However, proliferation of type II cells was not identified with light microscopy in this study. Because light microscopy has a limitation in the quantitative evaluation of the type II cell proliferation, we isolated type II alveolar cells and compared the number of type II cells that could be isolated from the lungs in pneumonectomized rats and from the control lungs. The total number of isolated type II cells was greater in pneumonectomized rats than in normal rats. There was no difference between the purity of type II cells isolated from pneumonectomized rats compared with those from normal rats. Therefore it is probable that proliferation of type II cells played a role, in part, in the enhanced alveolar fluid clearance observed in this study.
The third hypothesis was that the surface area of alveolar epithelial cells increased in pneumonectomized rats
14,15 and resulted in increased alveolar fluid clearance. Accelerated lung growth continues in a linear fashion until normal total lung mass is achieved 14 days after pneumonectomy.
16 The compensatory lung growth is consistent with a previous report in which surface area increased in association with the lung growth that reached to that of both lungs 14 days after pneumonectomy.
15 However, it is unlikely that the increase in surface area in pneumonectomized rats played a primary role in these studies. First, although we instilled the albumin solution into the right lung in this study, basal alveolar fluid clearance was not different from that in rats with instillation of the albumin solution into both lungs.
23 Second, alveolar fluid clearance in older rats with larger lungs was not different from alveolar fluid clearance in pneumonectomized rats.
22-24 Third, we previously instilled different volumes of the albumin solutions, ranging from 2 to 6 mL/kg body weight, indicating that alveolar surface area into which the albumin solution was instilled might be different, but alveolar fluid clearance was independent of instilled volume of the albumin solution.
4
The final hypothesis was that the function of sodium channel played a primary role in the increase in alveolar fluid clearance in pneumonectomized rats. To test this hypothesis, we administered amiloride, a sodium channel inhibitor, into the rat lungs immediately and 28 days after pneumonectomy and found that only amiloride-sensitive alveolar fluid clearance increased 28 days after pneumonectomy. In addition, we determined whether the synthesis of
-ENaC mRNA increased in pneumonectomized rats and found that
-ENaC mRNA expression was upregulated in both whole lung tissue and isolated type II cells. The upregulation of RNA and DNA after pneumonectomy
17 supports the possibility of sodium channel upregulation. Therefore it is likely that the function of sodium channels might be upregulated in alveolar epithelial cells after pneumonectomy. Upregulation of sodium channel might explain the mechanism for the improvement of alveolar fluid clearance in the absence of type II cell proliferation by means of light microscopic examination.
The upregulation of amiloride-sensitive alveolar fluid clearance has been reported in rat lungs that responded to several stimuli: endotoxin, keratinocyte growth factor, transforming growth factor
, and ß-adrenergic agonists.
4 In addition, several factors have been implicated in compensatory lung growth: postoperative changes in tissue inflation, elevated blood flow in the residual pulmonary vasculature, intraoperative or perioperative hypoxemia, and circulating or soluble factors by endocrine, paracrine, or autocrine mechanisms.
24 Further studies are needed to identify the factors that upregulated sodium channel expression in pneumonectomized rats.
Increased blood flow, endothelial damage with increased permeability, and inability of the lymphatics to transport interstitial fluid occur in the remaining lung early after pneumonectomy.
2 An accumulation of interstitial fluid can reduce alveolar fluid transport capacity.
3 Because alveolar fluid clearance increased late after pneumonectomy in this study, it is possible that the improvement of capillary leak and lymphatic drainage played a role in the increase in alveolar fluid clearance.
Because elevated plasma epinephrine levels 3 hours after pneumonectomy did not increase alveolar fluid clearance, we determined whether the remaining lungs in pneumonectomized rats were insensitive to an exogenous ß2-adrenergic agonist. We administered terbutaline, a selective ß2-adrenergic agonist, which has been commonly used to determine the effect of ß2-adrenergic agonist on alveolar fluid clearance in in vivo and ex vivo rat lungs
22,25,26 and in cultured type II alveolar epithelial cells from rat lungs.
27,28 Terbutaline increased alveolar fluid clearance in the remaining lungs 3 hours after pneumonectomy. The increased rates seemed to be maximal because the rates were similar to the peak rate that was observed in a dose-response relationship.
29 Therefore the ß2-adrenoceptors were normally responsive to terbutaline, and the results suggest that the plasma epinephrine levels 3 hours after pneumonectomy were insufficient to increase alveolar fluid clearance in pneumonectomized rats.
This study was carried out in the lungs in the absence of lung injury. Although the response to amiloride and ß2-adrenergic agonist is preserved in moderately injured lungs,
4,9,10,13 further studies are necessary to determine whether the remaining lungs in the presence of pulmonary edema after pneumonectomy are able to respond to such agents.
In summary, alveolar fluid clearance is preserved in the remaining right lung for 7 days and then improves at 14 and 28 days after pneumonectomy in rats. Both an upregulation of amiloride-sensitive sodium channels and an increase in the number of alveolar type II cells are responsible for the increase in alveolar fluid clearance. ß2-Adrenergic stimulation is capable of further upregulating alveolar fluid clearance at all time points after pneumonectomy. The time course of alveolar fluid clearance and responsiveness to a ß2-adrenergic agonist suggest that the capacity to recover from postpneumonectomy pulmonary edema might be maintained after lung resection.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Licker, J.-M. Tschopp, J. Robert, J.-G. Frey, J. Diaper, and C. Ellenberger Aerosolized Salbutamol Accelerates the Resolution of Pulmonary Edema After Lung Resection Chest, April 1, 2008; 133(4): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, J. Xu, G. Ma, M. Sagawa, M. Shimazaki, Y. Ueda, and T. Sakuma Chronic pulmonary artery occlusion increases alveolar fluid clearance in rats. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1213 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakuma, Y. Zhao, M. Sugita, M. Sagawa, H. Toga, T. Ishibashi, M. Nishio, and M. A. Matthay Malnutrition impairs alveolar fluid clearance in rat lungs Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1268 - L1274. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |